Results of Xarelto’s Clinical Trial Revealed

.

Results of Xarelto’s Clinical Trial Revealed

The results of clinical trials of Xarelto, a blood clot preventer drug, have been revealed. It has been informed that the drug has done far better in clinical trials as compared to the other medication which claims to prevent blood clots.

The drug Xarelto, which also has chemical name rivaroxaban, is a creation of Johnson & Johnson. During the clinical trial, about 5,000 patients were prescribed with the drug. The drug is not only effective in preventing blood clots, but is also safe to prescribe.

The manufacturer of the drug is of the view that in the coming time the drug might gain global recognition. Blood clots can cause serious health problems. They have the tendency of travelling to major organs like lung.

The clinical trial of the drug was led by Dr. Harry Buller. The results of the clinical trial were presented at American College of Cardiology during annual scientific sessions. While presenting the results, Dr. Harry said: “Rivaroxaban is just as good as standard treatment for pulmonary embolism -- these data are pretty convincing -- and this is an oral-only approach, which makes it very simple”.

While presenting the results, the results of other blood clotting preventers were also highlighted. Dr. Harry informed that about 1.1% of the patients taking Xarelto experienced major bleed as compared to 2.2% of the patients taking heparin and warfarin, blood clot preventer.

It has been informed that every year about 600,000 people succumbs to death in America because of blood clots. By introducing Xarelto for the clinical use, a large number of people could be saved from falling into the traps of death because of blood clots. Besides, Johnson & Johnson would also be able to add additional revenue of $500 million through the sales of Xarelto.


Latest News

Trib Total Media Plans to Sell Nine Newspapers including Four Daily and Five Wee
Twitter Plans to Employ More Women Next Year to Diversify Its Workforce
OPEC Oil Producers Prepared to Endure Lower Oil Prices But will Continue their P
Stanley Fischer Federal Reserve Vice Chairman Says No Decision Has Been Taken fo
Biggest Daily Climb Noted in the Oil Markets in Past Six Years
According to Sources Marchionne to Take over as Both CEO and Chairman of Ferrari
Consumer Spending and Inflation Drops in Japan Adding Pressure on Policymakers
Patterson Companies, Inc reports $29.7 million First Quarter Profit
Gap Announced by Beginning of Next year It will Phase Out On-Call Scheduling
Next Month Amazon Plans to Launch Its Video Streaming Service Tailored for Custo
Burger King Proposes to Create McWhopper with McDonald
Schlumberger Acquiring Cameron in a Cash and Stock Deal